Clinical

• 03-390  Phase II study of bevacizumab with gemcitabine and oxaliplatin in HCC.  Andrew Zhu, Keith Sutart and Charles Fuchs.

• 02-025  Ph I Bevacizumab with 5-FU and radiation therapy in Rectal Cancer.  Jeffrey Clark and Charles Fuchs.

• 02-317 Oral SU011 in patients with metastatic carcinoid or pancreatic neuroendocrine tumors.  Matthew Kulke, Keith Stuart and David Ryan.

• Understanding racial disparities in colon cancer outcomes.  John Ayanian (J. Clin Oncol 2003)

back

• 
  • Disease-based Programs
    • Breast Cancer
    • Cutaneous Oncology and Melanoma
    • Gastrointestinal Malignancies
      • -
        Specific Aims
      • -
        Funding Opportunities
      • -
        Members
      • +
        Collaborative Interactions
      • -
        Clinical Trials
      • -
        Resources
      • -
        Contact
    • Gynecologic Cancer
    • Head and Neck Cancer
    • Kidney Cancer
    • Leukemia
    • Lung Cancer
    • Lymphoma and Myeloma
    • Neuro-Oncology
    • Prostate Cancer
    • Sarcoma
  • Discipline-based Programs
  • Joining a Program
• 
• 
• 
• 
• 
•